Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin for Pre-emptive Treatment of Invasive Candidiasis in High Risk Surgical Subjects
NCT01122368Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 2, randomised, double-blind trial in invasive candidiasis comparing Micafungin with Placebo (2 arms). Primary endpoints: The incidence of Invasive Fungal Infection and Time from baseline to the first confirmation of Invasive Fungal Infection. Started Jul 2010; status: completed.
02
Drugs
micafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT01122368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122368.